85 related articles for article (PubMed ID: 20053567)
1. Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo.
De Saint-Hubert M; Mottaghy FM; Vunckx K; Nuyts J; Fonge H; Prinsen K; Stroobants S; Mortelmans L; Deckers N; Hofstra L; Reutelingsperger CP; Verbruggen A; Rattat D
Bioorg Med Chem; 2010 Feb; 18(3):1356-63. PubMed ID: 20053567
[TBL] [Abstract][Full Text] [Related]
2. Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent.
Fonge H; de Saint Hubert M; Vunckx K; Rattat D; Nuyts J; Bormans G; Ni Y; Reutelingsperger C; Verbruggen A
Bioorg Med Chem Lett; 2008 Jul; 18(13):3794-8. PubMed ID: 18524580
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeling of HYNIC-annexin V with technetium-99m for in vivo imaging of apoptosis.
Blankenberg FG; Vanderheyden JL; Strauss HW; Tait JF
Nat Protoc; 2006; 1(1):108-10. PubMed ID: 17406220
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
[TBL] [Abstract][Full Text] [Related]
5. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy.
Subbarayan M; Häfeli UO; Feyes DK; Unnithan J; Emancipator SN; Mukhtar H
J Nucl Med; 2003 Apr; 44(4):650-6. PubMed ID: 12679412
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
[TBL] [Abstract][Full Text] [Related]
8. Preparation and bioevaluation of (99m)Tc-HYNIC-annexin B1 as a novel radioligand for apoptosis imaging.
Luo QY; Wang F; Zhang ZY; Zhang Y; Lu HK; Sun SH; Zhu RS
Apoptosis; 2008 Apr; 13(4):600-8. PubMed ID: 18307043
[TBL] [Abstract][Full Text] [Related]
9. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy.
Rottey S; Slegers G; Van Belle S; Goethals I; Van de Wiele C
J Nucl Med; 2006 Nov; 47(11):1813-8. PubMed ID: 17079815
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V.
Penn DL; Kim C; Zhang K; Mukherjee A; Devakumar D; Jungkind D; Thakur ML
Nucl Med Biol; 2010 Jan; 37(1):29-34. PubMed ID: 20122665
[TBL] [Abstract][Full Text] [Related]
11. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
12. Patient dosimetry of intravenously administered 99mTc-annexin V.
Kemerink GJ; Liem IH; Hofstra L; Boersma HH; Buijs WC; Reutelingsperger CP; Heidendal GA
J Nucl Med; 2001 Feb; 42(2):382-7. PubMed ID: 11216539
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability.
Lorberboym M; Blankenberg FG; Sadeh M; Lampl Y
Brain Res; 2006 Aug; 1103(1):13-9. PubMed ID: 16806116
[TBL] [Abstract][Full Text] [Related]
15. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.
Tavaré R; Torres Martin De Rosales R; Blower PJ; Mullen GE
Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007
[TBL] [Abstract][Full Text] [Related]
16. Preliminary biological evaluation of novel (99m)Tc-Cys-annexin A5 as a apoptosis imaging agent.
Lu C; Jiang Q; Hu M; Tan C; Ji Y; Yu H; Hua Z
Molecules; 2013 Jun; 18(6):6908-18. PubMed ID: 23752473
[TBL] [Abstract][Full Text] [Related]
17. Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.
Vangestel C; Van de Wiele C; Mees G; Mertens K; Staelens S; Reutelingsperger C; Pauwels P; Van Damme N; Peeters M
Mol Imaging; 2012 Apr; 11(2):135-47. PubMed ID: 22469241
[TBL] [Abstract][Full Text] [Related]
18. Annexin V detection of lipopolysaccharide-induced cardiac apoptosis.
Pétillot P; Lahorte C; Bonanno E; Signore A; Lancel S; Marchetti P; Vallet B; Slegers G; Neviere R
Shock; 2007 Jan; 27(1):69-74. PubMed ID: 17172983
[TBL] [Abstract][Full Text] [Related]
19. Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124.
Dekker B; Keen H; Shaw D; Disley L; Hastings D; Hadfield J; Reader A; Allan D; Julyan P; Watson A; Zweit J
Nucl Med Biol; 2005 May; 32(4):403-13. PubMed ID: 15878510
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
